Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimization of Keverprazan-amoxicillin Dual Therapy for Eradicating Helicobacter Pylori Infection：a Multicenter, Prospective, Randomized Controlled Study

NCT06734260 is registered in ClinicalTrials.gov with Eighth Affiliated Hospital, Sun Yat-sen University as lead sponsor.

NCT NCT06734260
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06734260 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimization of Keverprazan-amoxicillin Dual Therapy for Eradicating Helicobacter Pylori Infection：a Multicenter, Prospective, Randomized Controlled Study
Lead sponsor
Eighth Affiliated Hospital, Sun Yat-sen University
Phase
Phase 3
Overall status
Recruiting
Start date
September 10, 2024
Completion date
January 10, 2026
Enrollment
477 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

helicobacter pylori eradication rate